374 related articles for article (PubMed ID: 3557977)
1. [Therapy of leprosy today].
Bahmer FA; Menzel S
Hautarzt; 1987 Jan; 38(1):1-3. PubMed ID: 3557977
[TBL] [Abstract][Full Text] [Related]
2. Multidrug therapy regimen for leprosy.
Firooz A
J Am Acad Dermatol; 2006 Dec; 55(6):1115; author reply 1115. PubMed ID: 17110233
[No Abstract] [Full Text] [Related]
3. [New WHO recommendations for the treatment of leprosy].
Acta Leprol; 1997; 10(4):189. PubMed ID: 9527754
[No Abstract] [Full Text] [Related]
4. [Antibacterial chemotherapy in leprosy: principles, objectives and recommendations].
Sansarricq H
Acta Leprol; 1986; 4(3):355-62. PubMed ID: 3551474
[No Abstract] [Full Text] [Related]
5. Treatment of Hansen's disease.
Alto WA
Am Fam Physician; 2002 Apr; 65(7):1280, 1282; author reply 1282. PubMed ID: 11996412
[No Abstract] [Full Text] [Related]
6. Experience with multidrug therapy in paucibacillary leprosy.
Bhate RD; Gupta CM; Chattopadhyay SP; Singh IP
Indian J Lepr; 1986; 58(2):244-50. PubMed ID: 3805797
[TBL] [Abstract][Full Text] [Related]
7. Combinations involving dapsone, rifampin, clofazimine, and ethionamide in the treatment of M. leprae infections in mice.
Shepard CC
Int J Lepr Other Mycobact Dis; 1976; 44(1-2):135-9. PubMed ID: 945234
[No Abstract] [Full Text] [Related]
8. Multi-drug therapy in leprosy: an effective method of control.
Indian J Lepr; 1984; 56(1):102-12. PubMed ID: 6548238
[TBL] [Abstract][Full Text] [Related]
9. Multidrug therapy in leprosy.
Manglani PR; Arif MA
J Indian Med Assoc; 2006 Dec; 104(12):686-8. PubMed ID: 17474286
[TBL] [Abstract][Full Text] [Related]
10. Dapsone drug resistance in the MDT era.
Roche PW; Neupane KD; Failbus SS; Butlin CR
Int J Lepr Other Mycobact Dis; 2000 Sep; 68(3):323-5. PubMed ID: 11221097
[No Abstract] [Full Text] [Related]
11. Multi-drug therapy of leprosy.
Ramu G
Indian J Lepr; 1985; 57(3):465-82. PubMed ID: 2420903
[No Abstract] [Full Text] [Related]
12. Minocycline is effective and cosmetically preferred to clofazimine by leprosy patients in New York.
Levis WR; Spencer TI; Ladizinski B
J Drugs Dermatol; 2010 Aug; 9(8):906. PubMed ID: 20684139
[No Abstract] [Full Text] [Related]
13. Recent trends in chemotherapy of leprosy.
Parikh DA; Maniar JK; Parikh AC; Ganapati R
J Assoc Physicians India; 1985 Sep; 33(9):593-5. PubMed ID: 3912375
[No Abstract] [Full Text] [Related]
14. Polytherapy in multibacillary leprosy patients in Nepal.
Samuel NM; Samual S; Fairbairn T; Adiga RB
Singapore Med J; 1985 Apr; 26(2):203-6. PubMed ID: 4035403
[No Abstract] [Full Text] [Related]
15. A overview of ocular leprosy after 2 decades of multidrug therapy.
Lewallen S; Courtright P
Int Ophthalmol Clin; 2007; 47(3):87-101. PubMed ID: 17667278
[No Abstract] [Full Text] [Related]
16. A retrospective study of the effect of modified multi-drug therapy in Nepali leprosy patients following the development of adverse effects due to dapsone.
Sapkota BR; Shrestha K; Pandey B; Walker SL
Lepr Rev; 2008 Dec; 79(4):425-8. PubMed ID: 19274989
[TBL] [Abstract][Full Text] [Related]
17. Clofazimine: new products. Major antileprous drug.
Prescrire Int; 1999 Apr; 8(40):44-6. PubMed ID: 10848059
[TBL] [Abstract][Full Text] [Related]
18. [Hansen's disease: case report and review of literature].
Concha R M; Cossio T ML; Salazar S I; Fich S F; Pérez C C; González B S
Rev Chilena Infectol; 2008 Feb; 25(1):64-9. PubMed ID: 18273528
[TBL] [Abstract][Full Text] [Related]
19. Committee 4: workshop on experimental chemotherapy of leprosy.
Int J Lepr Other Mycobact Dis; 1979 Jun; 47(2 Suppl):297-303. PubMed ID: 378876
[No Abstract] [Full Text] [Related]
20. Efficacy of WHO regimens in the management of leprosy patients with G6PD deficiency.
Mysore V; al-Suwaid AR
Int J Lepr Other Mycobact Dis; 1999 Jun; 67(2):159-61. PubMed ID: 10472369
[No Abstract] [Full Text] [Related]
[Next] [New Search]